Search research articles
Contact Us
Filters
Showing results (121-130 of 143) with videos related to
Page
of 15
Sort By:
The Pediatric Infectious Disease Journal
|
July 18, 2013
Undervaccination of perinatally HIV-infected and HIV-exposed uninfected children in Latin America and the Caribbean
Regina C M Succi, Margot R Krauss, D Robert Harris, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 24, 2012
Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: a randomized, placebo-controlled trial
Peter L Havens, Charles B Stephensen, Rohan Hazra, et al.
AIDS (London, England)
|
November 27, 2018
Eliminating perinatal HIV in the United States: mission possible?
Devasena Gnanashanmugam, Natella Rakhmanina, Keith W Crawford, et al.
Frontiers in Pediatrics
|
June 15, 2018
Surviving and Thriving-Shifting the Public Health Response to HIV-Exposed Uninfected Children: Report of the 3rd HIV-Exposed Uninfected Child Workshop
Amy L Slogrove, Renaud Becquet, Ellen G Chadwick, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
August 11, 2017
Associations of Low Vitamin D and Elevated Parathyroid Hormone Concentrations With Bone Mineral Density in Perinatally HIV-Infected Children
Denise L Jacobson, Charles B Stephensen, Tracie L Miller, et al.
JAMA Pediatrics
|
April 24, 2013
Cardiac status of children infected with human immunodeficiency virus who are receiving long-term combination antiretroviral therapy: results from the Adolescent Master Protocol of the Multicenter Pediatric HIV/AIDS Cohort Study
Steven E Lipshultz, Paige L Williams, James D Wilkinson, et al.
Antimicrobial Agents and Chemotherapy
|
December 25, 2003
Single-dose and steady-state pharmacokinetics of tenofovir disoproxil fumarate in human immunodeficiency virus-infected children
Rohan Hazra, Frank M Balis, Antonella N Tullio, et al.
The Lancet. HIV
|
November 26, 2020
Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept study
Theodore D Ruel, Edmund V Capparelli, Camlin Tierney, et al.
The Pediatric Infectious Disease Journal
|
November 16, 2017
Immunity After Childhood Vaccinations in Perinatally HIV-exposed Children With and Without HIV Infection in Latin America
Regina C M Succi, Margot R Krauss, D Robert Harris, et al.
Journal of the International AIDS Society
|
December 15, 2018
Mortality and losses to follow-up among adolescents living with HIV in the IeDEA global cohort collaboration
Azar Kariminia, Matthew Law, Mary-Ann Davies, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 143) with videos related to
Sort By:
Page
of 15
The Pediatric Infectious Disease Journal
|
July 18, 2013
Undervaccination of perinatally HIV-infected and HIV-exposed uninfected children in Latin America and the Caribbean
Regina C M Succi, Margot R Krauss, D Robert Harris, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 24, 2012
Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: a randomized, placebo-controlled trial
Peter L Havens, Charles B Stephensen, Rohan Hazra, et al.
AIDS (London, England)
|
November 27, 2018
Eliminating perinatal HIV in the United States: mission possible?
Devasena Gnanashanmugam, Natella Rakhmanina, Keith W Crawford, et al.
Frontiers in Pediatrics
|
June 15, 2018
Surviving and Thriving-Shifting the Public Health Response to HIV-Exposed Uninfected Children: Report of the 3rd HIV-Exposed Uninfected Child Workshop
Amy L Slogrove, Renaud Becquet, Ellen G Chadwick, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
August 11, 2017
Associations of Low Vitamin D and Elevated Parathyroid Hormone Concentrations With Bone Mineral Density in Perinatally HIV-Infected Children
Denise L Jacobson, Charles B Stephensen, Tracie L Miller, et al.
JAMA Pediatrics
|
April 24, 2013
Cardiac status of children infected with human immunodeficiency virus who are receiving long-term combination antiretroviral therapy: results from the Adolescent Master Protocol of the Multicenter Pediatric HIV/AIDS Cohort Study
Steven E Lipshultz, Paige L Williams, James D Wilkinson, et al.
Antimicrobial Agents and Chemotherapy
|
December 25, 2003
Single-dose and steady-state pharmacokinetics of tenofovir disoproxil fumarate in human immunodeficiency virus-infected children
Rohan Hazra, Frank M Balis, Antonella N Tullio, et al.
The Lancet. HIV
|
November 26, 2020
Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept study
Theodore D Ruel, Edmund V Capparelli, Camlin Tierney, et al.
The Pediatric Infectious Disease Journal
|
November 16, 2017
Immunity After Childhood Vaccinations in Perinatally HIV-exposed Children With and Without HIV Infection in Latin America
Regina C M Succi, Margot R Krauss, D Robert Harris, et al.
Journal of the International AIDS Society
|
December 15, 2018
Mortality and losses to follow-up among adolescents living with HIV in the IeDEA global cohort collaboration
Azar Kariminia, Matthew Law, Mary-Ann Davies, et al.
Page
of 15